Benoit Gillmann - BIO UV Chairman Founder
| ALTUV Stock | 2.15 0.02 0.94% |
Insider
Benoit Gillmann is Chairman Founder of BIO UV Group
| Phone | 33 4 99 13 39 11 |
| Web | https://www.bio-uv.com |
BIO UV Management Efficiency
The company has return on total asset (ROA) of 0.0347 % which means that it generated a profit of $0.0347 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0769 %, meaning that it generated $0.0769 on every $100 dollars invested by stockholders. BIO UV's management efficiency ratios could be used to measure how well BIO UV manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Thomas Lamy | Biosynex | N/A | |
| Denis Fortier | Eurobio Scientific SA | 55 | |
| Michal Fribourg | Chargeurs SA | 41 | |
| Denis Noharet | Chargeurs SA | N/A | |
| Gianluca Tanzi | Chargeurs SA | N/A | |
| JeanMichel Grandmougin | Eurobio Scientific SA | 62 | |
| Olivier Buquen | Chargeurs SA | 58 | |
| Federico Paullier | Chargeurs SA | N/A | |
| Philippe Haroche | Chargeurs SA | N/A | |
| Corinne Chansiaud | UV Germi SA | N/A | |
| Jacques Martin | Eurobio Scientific SA | N/A | |
| Andres Bordas | UV Germi SA | N/A | |
| Audrey Petit | Chargeurs SA | 37 | |
| Thomas Iff | Eurobio Scientific SA | N/A | |
| Sandrine Bordas | UV Germi SA | N/A | |
| Gustave Gauquelin | Chargeurs SA | N/A | |
| Willy Fortunato | UV Germi SA | N/A | |
| Herve MBA | Eurobio Scientific SA | 64 | |
| Joelle FabreHoffmeister | Chargeurs SA | 60 | |
Management Performance
| Return On Equity | 0.0769 | |||
| Return On Asset | 0.0347 |
BIO UV Group Leadership Team
Elected by the shareholders, the BIO UV's board of directors comprises two types of representatives: BIO UV inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO. The board's role is to monitor BIO UV's management team and ensure that shareholders' interests are well served. BIO UV's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO UV's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Isabelle Sost, Marketing Director | ||
| LaurentEmmanuel Migeon, COO Information | ||
| Pierre Decloedt, Technical Director | ||
| Simon Marshall, Deputy Director | ||
| Benoit Gillmann, Chairman Founder |
BIO Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO UV a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0769 | |||
| Return On Asset | 0.0347 | |||
| Profit Margin | 0.05 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 75.36 M | |||
| Shares Outstanding | 10.21 M | |||
| Shares Owned By Institutions | 7.09 % | |||
| Price To Book | 1.52 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 33.46 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BIO Stock Analysis
When running BIO UV's price analysis, check to measure BIO UV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO UV is operating at the current time. Most of BIO UV's value examination focuses on studying past and present price action to predict the probability of BIO UV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIO UV's price. Additionally, you may evaluate how the addition of BIO UV to your portfolios can decrease your overall portfolio volatility.